Management of pain
Note:
Symptomatic relief of cough (Hycodan)
Children 6 to 12 years of age for Symptomatic relief of cough (Hycodan)
Renal Dose Adjustment
Hepatic Dose Adjustment
Zohydro ER interacts with :
Pregnancy Category:C
Breastfeeding: Maternal use of maximum dosages of oral narcotics while breastfeeding can cause infant drowsiness, particularly newborns are sensitive to even small dosages of narcotic analgesics, in the first week of life, however small volumes of colostrum is secreted in the first 2 to 3 days postpartum hence newborn's dosage is limited. Once the mother's milk comes in, it is best to avoid oral hydrocodone (and combinations) and administer nonnarcotic analgesic if necessary. Maximum recommended dosage is 30 mg/day. Monitor the infant for drowsiness, adequate weight gain, and developmental milestones, immediately contact the physician if baby shows signs of increased sleepiness (more than usual), difficulty breastfeeding, breathing difficulties, or limpness. This information is based upon LactMed database (available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT last accessed 1 November 2013). Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from chlorpheniramine/hydrocodone, manufacturer recommends decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother
US Trade Name(s)
US Availability
Zohydro ER
Canadian Trade Name(s)
Canadian Availability
Hycodan
UK Trade Name(s)
UK Availability
Australian Trade Name(s)
Australian Availability